Liver fibrosis evaluation in lean steatotic liver disease patients

被引：0
|
作者：
Testino, Gianni [1 ,2 ,3 ]
机构：
[1] ASL3 Liguria, IRCCS San Martino Univ Hosp, Alcohol Reg Ctr, Unit Addict & Hepatol, Piazzale R Benzi 10, I-16132 Genoa, Italy
[2] ASL3 Liguria, Ctr Studi Mutual Self Help, Genoa, Italy
[3] ASL3, Dept Hlth Lifestyles, Genoa, Italy
来源：
MINERVA GASTROENTEROLOGY | 2024年
关键词：
D O I：
10.23736/S2724-5985.24.03686-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
    Cho, Yuri
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (05): : 215 - 222
  • [2] Immunopathogenesis of liver fibrosis in steatotic liver disease
    Woo, Chaerin
    Jeong, Won -Il
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (02)
  • [3] Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients
    Dabbah, Shoham
    Ben Yakov, Gil
    Kaufmann, Monika-Inda
    Cohen-Ezra, Oranit
    Likhter, Maria
    Davidov, Yana
    Ben Ari, Ziv
    MINERVA GASTROENTEROLOGY, 2024, 70 (03): : 322 - 331
  • [4] Prevalence of Steatotic Liver Disease and Liver Fibrosis Among Patients with Osteoarthritis (OA)
    Vassilopoulos, Athanasios
    Vassilopoulos, Stephanos
    Kalligeros, Markos
    Mylonakis, Eleftherios
    Reginato, Anthony M.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4227 - 4229
  • [5] Metabolic dysfunction-associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis
    Kobayashi, Natsuko
    Tada, Toshifumi
    Nishimura, Takashi
    Matono, Tomomitsu
    Yuri, Yukihisa
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Ikeda, Naoto
    Fukunishi, Shinya
    Hashimoto, Mariko
    Ohyanagi, Mitsumasa
    Enomoto, Hirayuki
    Iijima, Hiroko
    HEPATOLOGY RESEARCH, 2024, 54 (05) : 429 - 438
  • [6] STEATOTIC LIVER DISEASE IN LEAN PATIENTS IS ASSOCIATED WITH DIABETES, BUT NOT PNPLA3
    Espinoza, Angela Sato
    Chotiprasidhi, Perapa
    Wangensteen, Kirk
    HEPATOLOGY, 2024, 80 : S1930 - S1931
  • [7] Suitability of non-invasive tests in the evaluation of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
    Yague Parada, Alvaro
    Castaneda Agredo, Andres Felipe
    Calvo Hernandez, Rocio
    Gonzalez Guirado, Agustina
    Varela Silva, Andres
    Moran Ortiz de Solorzano, Marta
    Casanova Cabral, Michelle
    Polo Lorduy, Benjamin
    JOURNAL OF HEPATOLOGY, 2024, 80 : S598 - S598
  • [8] EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC LIVER-DISEASE
    DIODATI, G
    BONETTI, P
    PLEBANI, M
    RUGGE, M
    REALDI, G
    HEPATOLOGY, 1988, 8 (05) : 1302 - 1302
  • [9] Thy-1 restricts steatosis and liver fibrosis in steatotic liver disease
    Blank, Valentin
    Karlas, Thomas
    Anderegg, Ulf
    Wiegand, Johannes
    Arnold, Josi
    Bundalian, Linnaeus
    Le Duc, Gabriela-Diana
    Koerner, Christiane
    Ebert, Thomas
    Saalbach, Anja
    LIVER INTERNATIONAL, 2024, 44 (08) : 2075 - 2090
  • [10] Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Chen, Jiaxin
    Jian, Linge
    Guo, Yangkun
    Tang, Chengwei
    Huang, Zhiyin
    Gao, Jinhang
    ANTIOXIDANTS, 2024, 13 (06)
12345